Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, with millions suffering from narrowed or blocked arteries that restrict blood flow to the heart. For decades, metallic stents – bare-metal stents (BMS) and later drug-eluting stents (DES) – have been the gold standard for restoring vessel patency. While effective, these permanent implants carry long-term risks, including late stent thrombosis and the potential for hindering future re-interventions.

Enter Bioabsorbable Stents (BAS), also known as Bioresorbable Scaffolds (BRS). These revolutionary medical devices are designed to provide temporary structural support to the artery, facilitate healing, and then completely dissolve and be absorbed by the body over a period of months or years, leaving behind a restored, natural vessel. This transformative "dissolving solution" is poised to reshape interventional cardiology and is driving significant growth in a specialized, high-potential market.

Bioabsorbable Stents Market Segmentation

Biomaterial

• Polymeric Stents
• Metallic Stents
• Natural

Application

• Coronary Artery Disease
• Peripheral Artery Disease

End User

• Hospital
• Cardiac Centers

Geography

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Size and Growth: A Promising Horizon for Heart Health